Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Imane Frouni
Observed name:
Frouni, Imane
Institution:
Montreal Neurological Institute and Hospital
Observed institutions:
Montreal Neurological Institute and Hospital,
Centre Hospitalier de l’Université de Montréal,
Université de Montréal
ORCID:
0000-0001-6779-8713
Observed ORCID:
0000-0001-6779-8713
OpenAlex ID:
A5006406921
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset
2017
·
Adjia Hamadjida
, Stephen G Nuara
, et al.
·
Psychopharmacology
·
49
Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism
2019
·
Imane Frouni
, Adjia Hamadjida
, et al.
·
Neuropharmacology
·
47
Classic animal models of Parkinson’s disease: a historical perspective
2018
·
Adjia Hamadjida
, Imane Frouni
, et al.
·
Behavioural Pharmacology
·
38
Cognition and serotonin in Parkinson's disease
2022
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Progress in brain research
·
34
5-HT2A blockade for dyskinesia and psychosis in Parkinson’s disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review
2018
·
Cynthia Kwan
, Imane Frouni
, et al.
·
Experimental Brain Research
·
32
Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
2020
·
Cynthia Kwan
, Imane Frouni
, et al.
·
European Journal of Pharmacology
·
31
Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
2021
·
Cynthia Kwan
, Imane Frouni
, et al.
·
Neuropharmacology
·
26
The highly selective mGlu 2 receptor positive allosteric modulator LY‐487,379 alleviates l ‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease
2020
·
Adjia Hamadjida
, Lamia Sid‐Otmane
, et al.
·
European Journal of Neuroscience
·
26
Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat
2018
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Experimental Brain Research
·
26
Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset
2018
·
Adjia Hamadjida
, Stephen G. Nuara
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
26
Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
2021
·
Imane Frouni
, Sébastien Belliveau
, et al.
·
European Journal of Pharmacology
·
25
Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
2021
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Journal of Neural Transmission
·
21
Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat
2022
·
Imane Frouni
, Woojin Kang
, et al.
·
European Journal of Pharmacology
·
18
PDF
Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose
2019
·
Fleur Gaudette
, Dominique Bédard
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
17
Glutamate Modulation for the Treatment of Levodopa Induced Dyskinesia: A Brief Review of the Drugs Tested in the Clinic
2022
·
Imane Frouni
, Philippe Huot
·
Neurodegenerative Disease Management
·
15
Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmoset
2020
·
Stephen G. Nuara
, Adjia Hamadjida
, et al.
·
Journal of Neural Transmission
·
15
Metabotropic glutamate receptors in Parkinson's disease
2022
·
Cynthia Kwan
, Woojin Kang
, et al.
·
International review of neurobiology
·
14
Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the rat
2020
·
Cynthia Kwan
, Dominique Bédard
, et al.
·
Canadian Journal of Physiology and Pharmacology
·
13
PDF
The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
2023
·
Woojin Kang
, Stephen G. Nuara
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
11
Levodopa-induced Dyskinesia: A Brief Review of the Ongoing Clinical Trials
2021
·
Philippe Huot
, Woojin Kang
, et al.
·
Neurodegenerative Disease Management
·
10
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat
2020
·
Cynthia Kwan
, Imane Frouni
, et al.
·
Behavioural Pharmacology
·
10
Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
2022
·
Imane Frouni
, Cynthia Kwan
, et al.
·
European Journal of Pharmacology
·
9
Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brain
2021
·
Cynthia Kwan
, Catherine Lévesque
, et al.
·
Neuroscience Research
·
7
[3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain
2024
·
Imane Frouni
, Esther Kim
, et al.
·
Experimental Brain Research
·
5
PDF
Effect of the mGlu4 positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset
2023
·
Imane Frouni
, Cynthia Kwan
, et al.
·
Psychopharmacology
·
5
Show more works
View as search
Works count:
46
Citation count:
566
H-index:
15
I10-index:
21
Year
Topic
Type